Is Orion Oyj (HEL:ORNBV) Using Too Much Debt?
May 13
Have your own idea? Try our Stock Screener
Finnish (OMX) Pharma Industry Analysis
UpdatedMay 20, 2025
DataAggregated Company Financials
Companies1
- 7D4.9%
- 3M8.5%
- 1Y51.5%
- YTD31.2%
Over the last 7 days, the Pharma industry has dropped 2.2%, driven by pullbacks from every company within the industry. In the past year, the industry has gained 46%. Earnings are forecast to grow by 10% annually.
Industry Valuation and Performance
Has the Finnish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 20 May 2025 | €8.0b | €1.6b | €347.4m | 23.2x | 23.1x | 5.1x |
| Thu, 17 Apr 2025 | €6.9b | €1.5b | €329.9m | 21x | 21x | 4.5x |
| Sat, 15 Mar 2025 | €7.8b | €1.5b | €329.9m | 23.7x | 23.6x | 5x |
| Mon, 10 Feb 2025 | €7.4b | €1.4b | €331.1m | 22.2x | 22.3x | 5.2x |
| Wed, 08 Jan 2025 | €6.2b | €1.4b | €331.1m | 18.7x | 18.8x | 4.4x |
| Fri, 06 Dec 2024 | €6.3b | €1.4b | €331.1m | 19.1x | 19.2x | 4.4x |
| Sun, 03 Nov 2024 | €6.4b | €1.4b | €331.1m | 19.2x | 19.3x | 4.5x |
| Tue, 01 Oct 2024 | €6.9b | €1.3b | €231.7m | 29.8x | 29.9x | 5.5x |
| Thu, 29 Aug 2024 | €6.6b | €1.3b | €231.7m | 28.4x | 28.5x | 5.2x |
| Sat, 27 Jul 2024 | €5.8b | €1.2b | €217.1m | 68.7x | 26.8x | 4.8x |
| Mon, 24 Jun 2024 | €5.6b | €1.2b | €217.1m | 72.5x | 25.8x | 4.6x |
| Wed, 22 May 2024 | €5.3b | €1.2b | €217.1m | 63.6x | 24.3x | 4.3x |
| Fri, 19 Apr 2024 | €4.6b | €1.2b | €217.1m | 62.7x | 21.1x | 3.9x |
| Sun, 17 Mar 2024 | €5.0b | €1.2b | €217.1m | 62.1x | 23.1x | 4.2x |
| Tue, 13 Feb 2024 | €6.0b | €1.2b | €173.2m | 34.5x | 34.5x | 5.1x |
| Thu, 11 Jan 2024 | €5.9b | €1.2b | €173.2m | 34x | 34x | 5.1x |
| Sat, 09 Dec 2023 | €5.1b | €1.2b | €173.2m | 29.7x | 29.6x | 4.4x |
| Mon, 06 Nov 2023 | €5.1b | €1.2b | €173.2m | 29.7x | 29.7x | 4.4x |
| Wed, 04 Oct 2023 | €5.3b | €1.4b | €306.3m | 16.9x | 17.4x | 3.9x |
| Fri, 01 Sep 2023 | €5.3b | €1.4b | €306.3m | 17.3x | 17.3x | 3.9x |
| Sun, 30 Jul 2023 | €4.9b | €1.4b | €306.3m | 16x | 16.1x | 3.6x |
| Tue, 27 Jun 2023 | €5.3b | €1.3b | €336.0m | 15.8x | 15.8x | 3.9x |
| Thu, 25 May 2023 | €6.0b | €1.3b | €336.0m | 18x | 18x | 4.5x |
| Sat, 22 Apr 2023 | €6.5b | €1.3b | €349.5m | 18.5x | 18.5x | 4.8x |
| Mon, 20 Mar 2023 | €6.2b | €1.3b | €339.0m | 17.7x | 18.4x | 4.7x |
| Wed, 15 Feb 2023 | €6.6b | €1.3b | €339.0m | 18.7x | 19.4x | 4.9x |
| Fri, 13 Jan 2023 | €7.6b | €1.3b | €340.2m | 21.6x | 22.4x | 5.8x |
| Sun, 11 Dec 2022 | €7.1b | €1.3b | €340.2m | 20.1x | 20.8x | 5.4x |
| Tue, 08 Nov 2022 | €6.5b | €1.3b | €350.7m | 18.7x | 18.7x | 5x |
| Thu, 06 Oct 2022 | €6.2b | €1.1b | €201.7m | 30.8x | 30.8x | 5.8x |
| Sat, 03 Sep 2022 | €6.3b | €1.1b | €201.7m | 31x | 31x | 5.8x |
| Mon, 01 Aug 2022 | €6.6b | €1.1b | €201.7m | 32.5x | 32.5x | 6.1x |
| Wed, 29 Jun 2022 | €5.6b | €1.0b | €191.5m | 29.2x | 29.1x | 5.4x |
| Fri, 27 May 2022 | €5.3b | €1.0b | €191.5m | 27.9x | 27.9x | 5.1x |
Price to Earnings Ratio
27.9x
Current Industry PE
- There is only one company in the Finnish Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 22% per year over the last three years.
- Revenues for these companies have grown 15% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Finnish Healthcare industry?
| FI Market | 1.34% | |
| Healthcare | 3.55% | |
| Pharma | 4.86% | |
| Pharma | 4.86% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ORNBV Orion Oyj | €57.20 | 4.9% +€372.8m | 51.5% | PE23.2x | |
| HRTIS Herantis Pharma Oyj | €1.43 | 5.5% +€1.8m | 1.8% | PE-7x |